SPTBN2 and neoplasm: Furthermore, in patients with PTC in TCGA cohort and our local validated cohort (48 PTC patients), clinicopathological characteristics (tumor size, LNM, and disease stage) showed a high positive correlation with the high expression of SPTBN2.